Zobrazeno 1 - 10
of 299
pro vyhledávání: '"G, Auerswald"'
Publikováno v:
GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7be86ff6456759f889d8a4866134230d
https://doi.org/10.1055/s-0042-1760558
https://doi.org/10.1055/s-0042-1760558
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 24(4)
Introduction In haemophilia, recurrent joint bleeds are responsible for the development of chronic joint damage, because blood induces biochemical changes in joint structures. Joint degeneration is a long process, and structural damage is often prece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e8703ddefe1e17d99b0f3a1a365dab
https://pubmed.ncbi.nlm.nih.gov/29578254
https://pubmed.ncbi.nlm.nih.gov/29578254
Autor:
G, Auerswald, K, Kurnik, L M, Aledort, H, Chehadeh, A, Loew-Baselli, K, Steinitz, A J, Reininger, I, Woznica-Karczmarz
Publikováno v:
Haemophilia. 21:622-628
Introduction Inhibitory antibodies to factor VIII occur in about 30% of previously untreated patients (PUPs) and are the most serious complication of haemophilia A. It is unclear why some patients develop inhibitors and others do not. Aims The Early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cacb8a77e4a29d2f0877051e2d1db395
https://doi.org/10.1111/hae.12666
https://doi.org/10.1111/hae.12666
Autor:
Gili Kenet, Elena Santagostino, Carmen Altisent, Angelo Claudio Molinari, Manuel Carcao, Rolf Ljung, Pia Petrini, Michael Williams, Johannes Oldenburg, Cristoph Königs, Hervé Chambost, Carmen Escuriola-Ettingshausen, Anne Mäkipernaa, Krista Fischer, Helen Platokouki, George E Rivard, Ana Rosa Cid, Maria Elisa Mancuso, G. Auerswald, Karin Kurnik, H. Marijke van den Berg, Raina Liesner
Publikováno v:
Thrombosis and Haemostasis, 117(12), 2274. Schattauer GmbH
In children with severe haemophilia A, inhibitors to factor VIII (FVIII) usually develop during the first 50 treatment exposure days and are classified as low or high titre depending on the peak inhibitor titre being greater or less than 5 Bethesda u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86606275638cf136121fcfb785c7f58f
https://dspace.library.uu.nl/handle/1874/357677
https://dspace.library.uu.nl/handle/1874/357677
Publikováno v:
Thrombosis Research. 134:S27-S32
Prophylaxis is now an established treatment standard in haemophilia in Western Europe and the US with multiple studies demonstrating the clinical benefits of prophylaxis over on-demand treatment. In Western Europe in particular, prophylactic use of f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9821b4a61fb95af78cf7bf91503cc32f
https://doi.org/10.1016/j.thromres.2013.10.017
https://doi.org/10.1016/j.thromres.2013.10.017
Publikováno v:
Haemophilia. 19:438-444
Inhibitor development against von Willebrand factor, factor VIII or factor IX is one of the most severe complications of treating patients with von Willebrand's disease (VWD), haemophilia A or haemophilia B respectively. Continuous infusion of factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75c873931a1308400a9f4ba5665092c3
https://doi.org/10.1111/hae.12075
https://doi.org/10.1111/hae.12075
Publikováno v:
Critical Reviews in Oncology/Hematology. 83:11-20
The introduction of clotting factor concentrates led to major advances in hemophilia care. Rather than simply providing an alternative to plasma-derived concentrates, the introduction in the 1990s of recombinant concentrates added value to replacemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e45d2cde7dc6f95b8555bb75634e12a8
https://doi.org/10.1016/j.critrevonc.2011.08.001
https://doi.org/10.1016/j.critrevonc.2011.08.001
Publikováno v:
Hämostaseologie. 31:S38-S45
SummaryElectromyography (EMG) measures muscle electricity. It depends on muscle contraction and central motor control. Muscles react very sensitive on external signals (e. g. bleeding), The resulting changes can be shown in EMG. Patients, methods A f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab24d0f8956c7fd318f866668fadb004
https://doi.org/10.1055/s-0037-1619748
https://doi.org/10.1055/s-0037-1619748
Autor:
Elena Santagostino, Angiola Rocino, Rolf Ljung, G. Auerswald, Guy Young, Víctor Jiménez-Yuste, Massimo Morfini
Publikováno v:
Haemophilia. 16:386-412
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e439b77fcfa0692f0b767c0bdc4013d
https://doi.org/10.1111/j.1365-2516.2010.02182.x
https://doi.org/10.1111/j.1365-2516.2010.02182.x
Publikováno v:
Hämostaseologie. 30:S115-S118
SummarySevere haemophilia A was diagnosed postpartum in a newborn. The mother was known as a conductor (intron 22 inversion) and an uncle had a persistently high titer inhibitor after failed ITI.Due to a cephalhaematoma, a high-dose pdFVIII substitut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edbfc184b580d13666211958bb67cec5
https://doi.org/10.1055/s-0037-1619091
https://doi.org/10.1055/s-0037-1619091